Stay updated on Cemiplimab in NSCLC: European Clinical Trial
Sign up to get notified when there's something new on the Cemiplimab in NSCLC: European Clinical Trial page.

Latest updates to the Cemiplimab in NSCLC: European Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this is a minor site version change with no impact on study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new history entry 'Revision: v3.3.3' was added and the footer now omits 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.2%

- Check31 days agoChange DetectedAdded new entries for Study Status and Contacts/Locations on 2025-12-09, tied to version 19 from 2025-12-02. These updates reflect the current recruitment status and the study's locations and contacts in the record history.SummaryDifference0.4%

- Check53 days agoChange DetectedA new revision v3.3.2 was added and the previous revision v3.2.0 was removed from the Record History for NCT05363319.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved a site-wide notice about government funding and operating status from the page; it did not affect the core trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check74 days agoChange DetectedVersion 18 (submitted 2025-10-21) was added to the Record History, showing updated study status and contacts/locations. This reflects the latest submission and adds to the version trail.SummaryDifference0.1%

Stay in the know with updates to Cemiplimab in NSCLC: European Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cemiplimab in NSCLC: European Clinical Trial page.